Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 16, Number 6—June 2010

Letter

Atypical Chikungunya Virus Infections in Immunocompromised Patients

Article Contents

To the Editor: Chikungunya fever was first described in Tanganyika (now Tanzania) in 1952 and is now emerging in Southeast Asia. Chikungunya virus (CHIKV) infection, a self-limiting febrile illness, shares similarities with dengue fever such as headache and myalgia. Additionally, patients with CHIKV infection typically have arthralgia, arthritis, and tenosynovitis (1). Although usually benign, CHIKV infection may on rare occasions lead to neurologic and hepatic manifestations with high illness and mortality rates (2). We report 2 immunocompromised patients with CHIKV infection associated with peritonitis, encephalitis, and secondary bacterial infections.

Patient A, a 66-year-old Singaporean-Chinese man, had a history of chronic renal disease secondary to obstructive uropathy. His baseline creatinine level was 300–400 μmol/L. For 3 years, he had ingested traditional Chinese medicine, which we suspect was contaminated by steroids because he appeared cushingoid. An outbreak of CHIKV infection was reported at his workplace. He was admitted to National University Hospital, Singapore, in July 2008 with abdominal pain, vomiting, and fever of 1 day. He had no joint symptoms. Clinically, he had systemic inflammatory response syndrome complicated by acute-on-chronic renal failure. His creatinine level was elevated at 921 μmol/L on admission. A complete blood count showed leukocytosis (19.24 × 109 cells/L) with neutrophilia and thrombocytopenia (62 × 109 cells/L). Initial blood and urine cultures and serologic results were negative for dengue virus, but serum reverse transcription–PCR (RT-PCR) and indirect immunofluorescent assay for immunoglobulin G (IgG) (Euroimmun Medizinische Labordiagnostika, Lubeck, Germany) and IgM (CTK Biotech, Inc, San Diego, CA, USA) were positive for CHIKV (3,4). Computed tomographic scans of the abdomen showed dilated small bowel loops.

An urgent laparotomy did not show bowel perforation, but peritoneal cultures yielded Klebsiella pneumoniae, Escherichia coli, and Candida glabrata, and RT-PCR from the concentrated peritoneal fluid was positive for CHIKV (3). He was administered appropriate antimicrobial drugs. He required repeat laparotomies because of elevated intraabdominal pressure. He subsequently received broad spectrum antimicrobial drugs to treat secondary intraabdominal infections caused by P. aeruginosa and Enterococcus faecalis.

Ventilator-associated pneumonia also developed. Despite maximal support and prolonged antimicrobial therapy, this patient died after 5 months of hospitalization.

Patient B, a 45-year-old Malaysian–Chinese man with diabetes mellitus, had undergone a cadaveric liver transplant in 2001 for hepatitis B liver cirrhosis. He was receiving immunosuppressants (azathioprine and prednisolone). He was admitted in August 2008 after experiencing fever, headache, and abdominal bloating for 3 days. He had no neurologic symptoms. Acute self-limiting febrile illnesses with arthritis had occurred in his hometown; CHIKV infections were suspected.

Results of his examination on admission were normal, except for bilateral enlarged cervical lymph nodes. Chest radiograph results were unremarkable. He had mild transaminitis (alanine aminotransferase 173 U/L, aspartate aminotransferase 170 U/L), elevated C-reactive protein (107 mg/L), and thrombocytopenia (120 × 109 cells/L) without leukocytosis. Results of comprehensive serum and urine microbial studies were negative for posttransplant infections. Results of serum RT-PCR were negative for CHIKV, but IgG and IgM tests were positive for CHIKV.

Figure

Thumbnail of Magnetic resonance imaging of the brain of patient B, showing several nonspecific areas of enhancement (arrows), which suggests encephalitis, given the clinical scenario.

Figure. Magnetic resonance imaging of the brain of patient B, showing several nonspecific areas of enhancement (arrows), which suggests encephalitis, given the clinical scenario.

Brain magnetic resonance imaging was performed because of the patient’s persistent severe headache and transient drowsiness. It showed several nonspecific areas of enhancement, which suggested encephalitis, given the clinical scenario (Figure). However, a lumbar puncture was not performed, and hence, whether the patient’s cerebrospinal fluid contained CHIKV could not be determined. Bilateral frontoparietal white matter lesions with restricted diffusion has been suggested as an early sign of viral encephalitis (5). However, a retrospective series demonstrated that, in CHIKV encephalitis, abnormalities on magnetic resonance imaging were uncommon, and no pathognomonic features were found (6).

Hospital-acquired pneumonia also developed and was treated with broad-spectrum antimicrobial drugs. Bronchoscopic cultures were negative for CHIKV. The patient responded well to antimicrobial drugs, and his mental status was normal on discharge. He possibly had encephalitis associated with CHIKV infection, complicated by secondary hospital acquired pneumonia.

In this case, CHIKV was detected in peritoneal fluid, but because of the positive bacterial cultures, we are not confident about its causative role in patient A’s peritonitis. Although a series reported that 6 patients with CHIKV infection had perforated jejunal diverticula while receiving long-term nonsteroidal antiinflammatory drugs and steroids (7), the perforations were likely secondary to prolonged steroid use rather than CHIKV infection. In addition, both immunocompromised patients in our study had their CHIKV infections secondarily complicated by nosocomial infections. We note that other viral infections have been associated with bacterial translocation and secondary nosocomial infections (8). Whether these infections were linked to CHIKV infection or to the underlying chronic immunosuppressed state is unclear.

Both of our patients did not have the joint manifestations that are characteristic of CHIKV infection (9). More prospective studies are required to determine the full spectrum of clinical features of CHIKV infection in immunocompromised patients. Recently identified biomarkers may predict patients at risk for complications but we were unable to study them in our patients (10). Although most cases of CHIKV infection are self-limiting, clinicians should be alert to atypical presentations and severe complications in immunosuppressed patients.

Adrian C.L. Kee, Samantha Yang, and Paul TambyahComments to Author 
Author affiliations: National University Hospital, Singapore

References

  1. Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore). 2007;86:12337. DOIPubMed
  2. Lemant J, Boisson V, Winer A, Thibault L, André H, Tixier F, Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005–2006. Crit Care Med. 2008;36:253641. DOIPubMed
  3. Leo YS, Chow AL, Tan LK, Lye DC, Lin L, Ng LC. Chikungunya outbreak, Singapore, 2008. Emerg Infect Dis. 2009;15:8367. DOIPubMed
  4. Thein S, La Linn M, Aaskov J, Aung MM, Aye M, Zaw A, Development of a simple indirect enzyme-linked immunosorbent assay for the detection of immunoglobulin M antibody in serum from patients following an outbreak of chikungunya virus infection in Yangon, Myanmar. Trans R Soc Trop Med Hyg. 1992;86:43842. DOIPubMed
  5. Ganesan K, Diwan A, Shankar SK, Desai SB, Sainani GS, Katrak SM. Chikungunya encephalomyeloradiculitis: report of 2 cases with neuroimaging and 1 case with autopsy findings. AJNR Am J Neuroradiol. 2008;29:16367. DOIPubMed
  6. Robin S, Ramful D, Le Seach F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol. 2008;23:102835. DOIPubMed
  7. Palanivelu C, Rangarajan M, Rajapandian S, Maheshkumaar GS, Madankumar MV. Perforation of jejunal diverticula in steroids and nonsteroidal anti-inflammatory drug abusers: a case series. World J Surg. 2008;32:14204. DOIPubMed
  8. Lahiri M, Fisher D, Tambyah PA. Dengue mortality: reassessing the risks in transition countries. Trans R Soc Trop Med Hyg. 2008;102:10116. DOIPubMed
  9. Parola P, de Lamballerie X, Jourdan J, Rovery C, Vaillant V, Minodier P, Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis. 2006;12:14939.PubMed
  10. Ng LF, Chow A, Sun YJ, Kwek DJ, Lim PL, Dimatatac F, IL-1beta, IL-6, and RANTES as biomarkers of chikungunya severity. PLoS ONE. 2009;4:e4261. DOIPubMed

Figure

DOI: 10.3201/eid1606.091115

Related Links

Top of Page

Table of Contents – Volume 16, Number 6—June 2010

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Paul Tambyah, Department of Medicine, National University Hospital, 5 Lower Kent Ridge Rd, Singapore 119074





characters(s) remaining.

Comment submitted successfully, thank you for your feedback.

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO